1. Home
  2. ICCM

ICCM

IceCure Medical Ltd.

Logo IceCure Medical Ltd.

as 04-17-2024 4:00pm EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention, for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Founded: 2006 Country:
Israel
Israel
Employees: N/A City: N/A
Market Cap: 57.2M IPO Year: N/A
Target Price: $2.95 AVG Volume (30 days): 694.9K
Analyst Decision: Strong Buy Number of Analysts: 2
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -0.32 EPS Growth: N/A
52 Week Low/High: $0.52 - $1.57 Next Earning Date: 04-03-2024
Revenue: $3,229,000 Revenue Growth: 4.67%
Revenue Growth (this year): 50.7% Revenue Growth (next year): 219.79%

Share on Social Networks:

Latest IceCure Medical Ltd. News

ICCM Breaking Stock News: Dive into ICCM Ticker-Specific Updates for Smart Investing

All ICCM News